ArticleJournal of cellular and molecular medicine2012

Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles.

Claudio Cabello-Verrugio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.